Home > Research > Publications & Outputs > Human IMR-32 neuroblastoma cells as a model cel...
View graph of relations

Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research. / Neill, D; Hughes, D; Edwardson, J A et al.
In: Journal of Neuroscience Research, Vol. 39, No. 4, 1994, p. 482-493.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Neill, D, Hughes, D, Edwardson, JA, Rima, BK & Allsop, D 1994, 'Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research', Journal of Neuroscience Research, vol. 39, no. 4, pp. 482-493. https://doi.org/10.1002/jnr.490390415

APA

Neill, D., Hughes, D., Edwardson, J. A., Rima, B. K., & Allsop, D. (1994). Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research. Journal of Neuroscience Research, 39(4), 482-493. https://doi.org/10.1002/jnr.490390415

Vancouver

Neill D, Hughes D, Edwardson JA, Rima BK, Allsop D. Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research. Journal of Neuroscience Research. 1994;39(4):482-493. doi: 10.1002/jnr.490390415

Author

Neill, D ; Hughes, D ; Edwardson, J A et al. / Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research. In: Journal of Neuroscience Research. 1994 ; Vol. 39, No. 4. pp. 482-493.

Bibtex

@article{1f281a219bbb4b91b021284621a821ad,
title = "Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research",
abstract = "The present study investigated expression and processing of amyloid precursor protein by neuronally differentiated IMR-32 neuroblastoma cells. APP mRNA in these cells was found to consist of approximately 58% APP695, 38% APP751, and <4% APP770. APP-immunoreactive bands detected in western blots of cellular protein extracts were only detected by anti-APP antibodies to peptides with strong homology to APLP2, suggesting that these bands represent APP-like proteins and not APP itself. This result suggests that previous studies claiming immunodetection of cellular forms of APP may have to be re-evaluated. Four main species of C-terminal truncated, secreted APP were detected in blots of protein extracts from medium conditioned by these cells. The immunoreactive profile of these bands suggested a cleavage site N-terminal to the Lys16-Leu17 bond of alpha-secretase. This, together with differences in number and molecular mass of APP-immunoreactive bands between secreted APP from IMR-32 cells and that from the commonly used PC-12 cells, suggests differences in APP processing between these two neuronally differentiated cell lines. In theory, IMR-32 cells being of human neuronal origin may be a more appropriate cell line to study APP-processing in relation to Alzheimer's disease than the rat phaeochromocytoma PC-12 cell line. Therefore, these detected differences warrant further investigation. Additionally IMR-32 cells under certain tissue culture conditions can form intracellular fibrillary material that reacts with anti-PHF specific antibodies. Neuronally differentiated IMR-32 cells could therefore be used as a model system to investigate possible interactions between APP-processing and PHF formation.",
keywords = "Alzheimer Disease, Amino Acid Sequence, Amyloid beta-Protein Precursor, Antibodies, Antibodies, Monoclonal, Base Sequence, Blotting, Northern, Cell Differentiation, Cell Line, Humans, Immunohistochemistry, Models, Neurological, Molecular Sequence Data, Neuroblastoma, Neurons, Oligonucleotide Probes, Peptide Fragments, RNA, Messenger, Sequence Homology, Amino Acid, Tumor Cells, Cultured",
author = "D Neill and D Hughes and Edwardson, {J A} and Rima, {B K} and D Allsop",
year = "1994",
doi = "10.1002/jnr.490390415",
language = "English",
volume = "39",
pages = "482--493",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research

AU - Neill, D

AU - Hughes, D

AU - Edwardson, J A

AU - Rima, B K

AU - Allsop, D

PY - 1994

Y1 - 1994

N2 - The present study investigated expression and processing of amyloid precursor protein by neuronally differentiated IMR-32 neuroblastoma cells. APP mRNA in these cells was found to consist of approximately 58% APP695, 38% APP751, and <4% APP770. APP-immunoreactive bands detected in western blots of cellular protein extracts were only detected by anti-APP antibodies to peptides with strong homology to APLP2, suggesting that these bands represent APP-like proteins and not APP itself. This result suggests that previous studies claiming immunodetection of cellular forms of APP may have to be re-evaluated. Four main species of C-terminal truncated, secreted APP were detected in blots of protein extracts from medium conditioned by these cells. The immunoreactive profile of these bands suggested a cleavage site N-terminal to the Lys16-Leu17 bond of alpha-secretase. This, together with differences in number and molecular mass of APP-immunoreactive bands between secreted APP from IMR-32 cells and that from the commonly used PC-12 cells, suggests differences in APP processing between these two neuronally differentiated cell lines. In theory, IMR-32 cells being of human neuronal origin may be a more appropriate cell line to study APP-processing in relation to Alzheimer's disease than the rat phaeochromocytoma PC-12 cell line. Therefore, these detected differences warrant further investigation. Additionally IMR-32 cells under certain tissue culture conditions can form intracellular fibrillary material that reacts with anti-PHF specific antibodies. Neuronally differentiated IMR-32 cells could therefore be used as a model system to investigate possible interactions between APP-processing and PHF formation.

AB - The present study investigated expression and processing of amyloid precursor protein by neuronally differentiated IMR-32 neuroblastoma cells. APP mRNA in these cells was found to consist of approximately 58% APP695, 38% APP751, and <4% APP770. APP-immunoreactive bands detected in western blots of cellular protein extracts were only detected by anti-APP antibodies to peptides with strong homology to APLP2, suggesting that these bands represent APP-like proteins and not APP itself. This result suggests that previous studies claiming immunodetection of cellular forms of APP may have to be re-evaluated. Four main species of C-terminal truncated, secreted APP were detected in blots of protein extracts from medium conditioned by these cells. The immunoreactive profile of these bands suggested a cleavage site N-terminal to the Lys16-Leu17 bond of alpha-secretase. This, together with differences in number and molecular mass of APP-immunoreactive bands between secreted APP from IMR-32 cells and that from the commonly used PC-12 cells, suggests differences in APP processing between these two neuronally differentiated cell lines. In theory, IMR-32 cells being of human neuronal origin may be a more appropriate cell line to study APP-processing in relation to Alzheimer's disease than the rat phaeochromocytoma PC-12 cell line. Therefore, these detected differences warrant further investigation. Additionally IMR-32 cells under certain tissue culture conditions can form intracellular fibrillary material that reacts with anti-PHF specific antibodies. Neuronally differentiated IMR-32 cells could therefore be used as a model system to investigate possible interactions between APP-processing and PHF formation.

KW - Alzheimer Disease

KW - Amino Acid Sequence

KW - Amyloid beta-Protein Precursor

KW - Antibodies

KW - Antibodies, Monoclonal

KW - Base Sequence

KW - Blotting, Northern

KW - Cell Differentiation

KW - Cell Line

KW - Humans

KW - Immunohistochemistry

KW - Models, Neurological

KW - Molecular Sequence Data

KW - Neuroblastoma

KW - Neurons

KW - Oligonucleotide Probes

KW - Peptide Fragments

KW - RNA, Messenger

KW - Sequence Homology, Amino Acid

KW - Tumor Cells, Cultured

U2 - 10.1002/jnr.490390415

DO - 10.1002/jnr.490390415

M3 - Journal article

C2 - 7884825

VL - 39

SP - 482

EP - 493

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 4

ER -